The journal Alzheimer’s & Dementiapublished the results of a lipidomics study, which found significant differences in plasma lipids associated with Alzheimer’s disease (AD), but only among women. This study was a post hoc analysis of data from two cohorts, the AddNeuroMed and Dementia Case Register cohorts, both conducted among European populations. A total of 841 participants were involved, including 306 diagnosed with AD, 165 with mild cognitive impairment (MCI), and 370 cognitively hea...| Biotics Research Blog
The Ketogenic Diet: An Unrivaled Approach to Combating Alzheimer’s Disease Author’s note: As a Licensed Mental Health Counselor with 16 years of private practice experience, I’ve spent the last six years transitioning individuals with mental illness and neurological disorders onto a ketogenic diet. It took me a long time to write this article, and IContinue reading "Ketogenic Diet and Alzheimer’s Disease"| Mental Health Keto
As we grow older, all parts of our bodies experience changes, including our brains. Forgetfulness is a common part of aging, and everyone experiences mild memory lapses from time to time. For example, we forget where we left things, people’s... The post Normal memory loss, dementia, or Alzheimer’s? appeared first on London Drugs Blog.| London Drugs Blog
Homethrive has partnered with Embrace Prevention Care to support dementia patients and their caregivers.| Homethrive
Alzheimer’s disease and other forms of dementia profoundly impact millions of individuals and their families. Often diagnosed too late for effective intervention, these conditions highlight the critical need for early detection. Early screening trials for Alzheimer’s are emerging as a game-changing approach, offering hope for earlier intervention, innovative treatments, and a better quality of life. … Memory Loss and Alzheimer’s: How Early Screening Trials Could Change Lives Read More »| Princeton Medical Institute
Apologies for not posting for a while. Fall 2024 was a busy time for me, with travel to give talks in Australia and Singapore and some events in the US. Instead of trying to catch up with everythin…| Science Integrity Digest
Alzheimer’s and dementia are complex, progressive conditions that impact millions of individuals and their families around the world. In the pursuit of effective treatments, clinical trials play an essential role, driving advancements in care, expanding treatment options, and offering hope to those affected. Through rigorous testing and research, clinical trials not only pave the way … The Role of Clinical Trials in Advancing Alzheimer’s and Dementia Care Read More »| Princeton Medical Institute
Last week, NICE echoed its earlier position on the Alzheimer’s drug lecenamab and advised that the benefits of donanemab did not, based on current evidence outweigh the costs of making it available on the NHS concluding that ‘The costs of providing donanemab, including regular infusions and intensive monitoring for serious side effects, balanced against the […]| Making rights make sense
An overview of general news and articles about science integrity and some cases that I have worked on. Science sleuths Neuroscientist and top NIH official under scrutiny Q-Collar under scrutiny Nobel prize winner under scrutiny Paper Mills New ORI regulations The US Office of Research Integrity updated its regulations on handling research misconduct allegations. Key … Continue reading "Science Integrity Digest, September 2024"| Science Integrity Digest
Your monthly digest of science integrity news. General Science Integrity News Sleuthing Legal threats for science critics Federal and institutional investigations Publishers taking action Games Artificial intelligence and science New Publication and Editorials Retraction Watch’s Weekend Reads:| Science Integrity Digest
A round-up from last month, with news articles about science integrity, retractions of several highly cited papers in the fields of Alzheimer’s disease and stem cell research, generative AI a…| Science Integrity Digest
A compound in black pepper, cinnamon, cloves, and many cannabis varietals acts on several targets that impact the endocannabinoid system. The post Beta-Caryophyllene: Terpene Powerhouse appeared first on Project CBD.| Project CBD
Case study highlights clinical implications of PPAR activation by cannabidiol. The post CBD Enhances Glucose Metabolism via Nuclear Receptors appeared first on Project CBD.| Project CBD
What role does this cannabinoid receptor play in emotional & cognitive disorders even though it's not concentrated in the central nervous system? The post Mental Health & the CB2 Receptor appeared first on Project CBD.| Project CBD
It's time for another Taking Stock post. In case you didn't know, I do quarterly Taking Stock posts each year (so four). This will be the second one for 2024. The first Taking Stock post for 2024 can be found here! This Taking Stock post is a bit of a different one. I usually like| Write of the Middle -
Using samples and data from the MURDOCK Study, Duke University researchers have found more evidence linking the disruption of a key metabolic pathway with the development of Alzheimer’s disease.| North Carolina Research Campus